FibroGen, Inc. fled a registration statement on Form S-1 with the SEC for maximum $125 million IPO of its common ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE